Aquestive Therapeutics, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Aquestive Therapeutics, Inc. on January 8, 2021. The filing serves to disclose an investor presentation intended for meetings with institutional investors and analysts. The company is incorporated in Delaware and its common stock trades on the Nasdaq Global Market under the symbol AQST. The registrant is classified as an emerging growth company.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report acts as a conduit for an attached investor presentation (Exhibit 99.1) rather than a standalone financial statement.
Material Changes
The filing states that the attached investor presentation replaces in its entirety all prior investor presentations filed by the Company. No specific financial or operational changes are detailed within the text of this 8-K form itself.
Guidance, Outlook, and Risks
Management commentary and outlook are contained within the attached investor presentation (Exhibit 99.1), which is available on the company's website. The filing explicitly notes that the information in Item 7.01 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated. The company reserves the right to amend or update this information at any time.
Key Facts for Investor Verification
- Review Exhibit 99.1 (Investor Presentation) for actual financial data, guidance, and strategic outlook, as this 8-K only references the document.
- Verify the current availability of the presentation on the company website (www.aquestive.com), as the company reserves the right to discontinue access.
- Note that the information provided is not subject to the liabilities of Section 18 of the Exchange Act.
- Confirm the company's status as an emerging growth company and its election regarding extended transition periods for accounting standards.